Panbela Therapeutics, Inc

Stemonix, Inc, based in Maple Grove, MN, is a leading provider of human-first drug discovery solutions, partnering with biopharma, academic, and government institutions. Their innovative microBrain platform offers ready-to-use multi-well plates containing functional microtissues derived from human induced pluripotent stem cells (iPSC), enabling high-throughput human drug screening and significantly reducing costs and time for their partners. With consistent cultures of neurons and astrocytes co-differentiated from a single donor source, Stemonix's microBrain platform brings human biology to the bench in both 2D and 3D formats. Their Assay AnalytiX platform provides advanced analysis for more valuable and robust data, helping to accelerate the development of new treatments and get medications to patients faster.Generated from the website

Located in the vibrant city of Minneapolis, MN, Novum Therapeutics offers a state-of-the-art sleep clinic for those seeking expert care and solutions for their sleep disorders. Nestled in the heart of the community, this clinic is dedicated to providing personalized treatment plans tailored to each individual's unique needs and sleep challenges. At Novum Therapeutics, patients can expect a team of experienced sleep specialists who utilize cutting-edge technology and the latest research to diagnose and address various sleep disorders effectively. Whether you struggle with insomnia, sleep apnea, or other conditions impacting your rest, this clinic is committed to helping you achieve a better night's sleep and improved overall well-being. Generated using this place's available information

MD Biosciences, Inc is a leading preclinical contract research organization (CRO) specializing in pain, neurodegeneration, and neuroinflammation. With a team of experienced neuroscientists, they offer expertise in developing complex predictive studies to enhance the translatability of preclinical data. Their GLP-certified laboratory is fully equipped with behavioral suites and offers both rodent and pig models to bridge the gap between preclinical and clinical studies. MD Biosciences, Inc goes beyond standard behavior analysis by utilizing outcomes comparable to those measured in patients, such as in vivo electrophysiology, to provide clinically relevant preclinical data. Their focus on bringing insight and methods that increase the value of each study and the translatability of the data makes them an expert partner dedicated to meeting drug development needs in the field of neuroinflammatory, neurodegenerative, pain, and other CNS diseases.Generated from the website